MedTrace Logo

Effect of Methylphenidate on Connectivity

NCT01764672 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2014-02-26

No results posted yet for this study

Summary

The goal of the study is to use graph theory to examine how the organization of the functional brain network may be altered by the administration of methylphenidate. This effect is to be compared between methylphenidate intake and placebo intake, as well as between healthy adult males and adult males with a diagnosis of Attention Deficit Hyperactivity Disorder.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Methylphenidate

Oral dose 40mg (2 x 20mg)

OTHER

Placebo

Oral intake of 2 placebo tablets

Sponsors & Collaborators

  • Netherlands Brain Foundation

    collaborator OTHER

  • Iris Sommer

    lead OTHER

Principal Investigators

  • Iris EC Sommer, Prof, Dr. · UMC Utrecht

  • Martijn P Van den Heuvel, Dr. · UMC Utrecht

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01764672 on ClinicalTrials.gov